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Abstract
Bipolar disorder (BD) is a chronic condition characterized by mood 
swings that is not rarely presented in adolescents. The presence of 
comorbid disorders is believed to affect negatively the patient’s state. 
It has been investigated predictors and risk factors for this disease and 
it might be a path to get more understanding about the psychopatho-
logy underneath the BD. The concomitant substance use disorders in 
a bipolar individual are a challenge to achieve a successful treatment. 
The diagnosis of BD is still not clearly stablished, as well as the most 
effective treatment is still controversial and undefined. Suicide in a 
depressive frame of bipolar disorder is one of the biggest concerns 
for the medicine field.
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Bipolar disorder which is not uncommon in youth [1, 2] is often charac-
terized by continuous, rapid-cycling, irritable, and mixed symptoms of 
depression and mania or hypomania. It may co-occur with disruptive 
behavior disorders, particularly attention deficit hyperactivity disorder 
(ADHD) or conduct disorder [1, 3].
Similar to adults with BD, youth can be diagnosed with several 
subtypes of bipolar disorders including BD-I (periods of mania and ma-
jor depression), BD-II (episodes of hypomania and major depression), 
Mixed episodes (symptoms of mania and depression occurring within 
the same 2-week time frame), cyclothymia (periods of hypomania and 
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mild depressions), and BP-not otherwise specified 
(BP-NOS) [4, 5, 6, 7, 8, 9, 10, 11].
In early-onset bipolar disorder, the onset of 
symptoms occurs before 18 years of age [11, 12, 
13, 14, 15]. These patients suffer long-term con-
sequences that substantially impair their ability to 
perform normal func¬tions of daily life, conse-
quently having devastating impact on their school 
performance, family relationships, and social inte-
ractions [11, 16].
The exact prevalence of pediatric bipolar disorder 
is unknown, but it is estimated that bipolar spec-
trum conditions may affect 2% of children and ado-
lescents worldwide [11, 17, 18]. Half to two-thirds of 
patients with bipolar disorder have their first mood 
episode before age 18 [19-21], and pediatric bipolar 
disorder is highly recurrent [19].
The early signs that predict the continued course 
of adolescent mood disorders are not well establis-
hed. Thus, we do not know which adolescents with 
a mood disorders will develop BD, major depressive 
disorder (MDD), or neither as adults [22]. Adolescent 
BP is associated with early signs such as mood labi-
lity or swings, anxiety, hyperarousal, somatic com-
plaints, behavioral dysregulation, attention difficul-
ties and school problems [22, 23, 24, 25, 26, 27, 
28]. Disruptive behavioral disorders, in combination 
with mood changes, have been identified as more 
specific markers of the early onset of BPD [23, 29, 
30, 31, 32, 33]. It has also been found that the pre-
sence of anxiety disorders, especially panic disorder, 
might be a marker as well [23, 34, 35, 36, 37].
Studies have described a number of correlates 
of comorbid substance use disorders (SUD) among 
adolescents with BP, including older age, panic disor-
der, oppositional defiant disorder/conduct disorder 
(ODD/CD), psychosis, family history of SUD, and pre-
vious alcohol experimentation [38, 39, 40, 41, 42]. 
The presence of comorbid SUD poses a substantial 
challenge in the treatment of patients with severe 
mental disorders [43, 44]. Comorbid SUDs are as-
sociated with more severe psychotic and depressive 
symptoms [43, 45, 46], more frequent hospitaliza-
tions [43, 47], more involuntary hospitalization [43, 
48], and poorer treatment response and outcome 
[43, 49, 50]. Most studies of comorbidity between 
severe mental disorders and SUD are based on data 
from surveys or clinical samples. Results from repre-
sentative US population surveys have indicated that 
30-50 % of individuals with psychotic illness [43, 51, 
52] or affective mood disorder [43, 53, 54] have a 
comorbid alcohol use disorder (AUD) or non-alcohol 
drug use disorder (DUD). More recently, two smaller 
clinical studies from Scandinavian populations have 
reported similar results with prevalences of 20-30 
% for SUD in schizophrenia [43, 55, 56] and bipolar 
disorder [43, 50, 57].
Youth can be diagnosed with mania or hypo-
mania using the existing Diagnostic and Statistical 
Manual of Mental Disorder (DSM) criteria for adults 
[58, 59, 60, 61, 62, 63, 64]. Diagnosis of Bipolar 
spectrum disorders (BPSD) in youth remains a diffi-
cult but important clinical responsibility. Assessment 
strategies are needed that are inexpensive, easy to 
implement, have good predictive power, and simul-
taneously combine multiple pieces of clinical infor-
mation to increase or decrease the probability of 
BPSD [65, 66].
Research into the treatment of BD in children 
and adolescents has increased in recent years, es-
pecially regarding the use of Second-Generation 
Antipsychotics (SGAs). However, many uncertainties 
remain. Current algorithms suggest starting with 
monotherapy and then progressing to combination 
treatment with two different classes of drugs [67]. 
To control mood episodes and prevent relapse, the-
se pediatric patients require careful treatment [10, 
68]. Pharmacotherapeutic options for treating bipo-
lar disorder in adolescents now also include several 
atypical antipsychotics [10, 69] with four medica-
tions currently approved for this population by the 
US Food and Drug Administration (FDA): aripipra-
zole, olanzapine, quetiapine, and risperidone. The 
emergence of atypical antipsychotics has provided 
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treatments with fewer neurological side effects and 
greater tolerability [10, 70].
Although no specific SGA has proved to be more 
effective than others, available meta-analyses and 
comparative studies of RPCTs suggest that SGAs 
are more effective than traditional mood stabilizers. 
Furthermore, a head-to-head comparison of risperi-
done vs. lithium and divalproex showed that rispe-
ridone was superior in terms of efficacy, but with 
more metabolic side effects [67, 71].
Until recently, patients with bipolar disorder 
were rarely offered psychological therapies. The 
treatment of bipolar disorder is challenging as it 
does not only aim at resolving acute episodes, but 
also at preventing recurrences and assuring com-
plete inter-episode recovery in terms of symptom 
remission and restoration of functioning. There is 
evidence from randomized, controlled trials that 
psychotherapy is an effective adjunct to medica-
tion in relapse prevention and episode stabilization 
among bipolar patients [72]. According to a recent 
meta-analysis, there is a significant reduction in re-
lapse rate with adjunctive psychotherapy compared 
to standard treatment alone [72, 73]. A recent sys-
tematic review concluded that as adjuncts to me-
dication cognitive-behavioural therapy (CBT) and 
family-focused therapy (FFT) are efficacious with 
respect to the reduction of depressive symptoms, 
with interpersonal and social rhythm therapy (IPSRT) 
possibly efficacious [72, 74].
The ability to recognize facial emotional expres-
sions is a fundamental skill that is necessary for 
successful social interaction and mood regulation. 
Borzorg et al. confirmed that adolescents with BD 
showed overall deficits in the accurate identifica-
tion of emotions. The detection of emotion was 
significantly lower in the patient group compared to 
normal adolescents while they were viewing angry 
faces. This ability was also (nearly significant) lower 
while they needed to recognize sad and happy fa-
ces. Moreover, the time taken to detect emotional 
faces was longer in adolescents with BD compared 
to the normal developing adolescents. This process 
was particularly slower in identifying happy and 
neutral faces. These findings could be interpreted 
that youths with bipolar disorder have some pro-
blems in recognizing emotional faces in terms of 
accuracy and speed even when they are free from 
acute symptoms [1].
There are a few comorbid disorder associated 
with Bipolar Disorder. The scarce literature available 
suggests that Attention-deficit/hyperactivity Disor-
der (ADHD) and BD might share or promote syner-
gistic neuropsychological deficits when comorbid. 
Children and adolescents presenting BD and comor-
bid ADHD show greater impairment in speed pro-
cessing and interference control [75]. Also, there is 
conduct disorder (CD) comorbidity, the most impor-
tant negative predictor of treatment nonresponse in 
BD children and adolescents [76, 77]. Youth with CD 
and BD presented higher rates of global aggression 
at the baseline, namely impulsive aggression, com-
pared with those with either BD or CD alone, more 
frequent substance abuse, and poorer response to 
treatments [76, 78].
Patients with bipolar disorder have elevated mor-
tality rates in comparison with the general popula-
tion [79, 80]. The excess mortality can be subdivided 
into deaths from avoidable causes and other deaths 
that are termed "unavoidable" [79, 81]. Suicide is 
a leading cause of avoidable deaths in bipolar di-
sorder. Comorbid alcohol and drug abuse must be 
identified and treated since it elevates the risk for 
suicide [79, 82]. Lithium and anticonvulsant mainte-
nance treatments have been the mainstays of suici-
de prevention in patients with major affective disor-
ders [79, 83].The evidence supports the efficacy of 
cognitive behavioural therapy (CBT), in combination 
with pharmacological treatment for the prevention 
of relapse and of suicidal behavior [79, 84].
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